Shanghai's Biotech Boom: The Rise of China's "Medicine Valley" in the Yangtze Delta

The Biotech Transformation: 2025 Status ReportKey industry metrics:- 42% of China's biopharmaceutical patents originate in Shanghai- 18 FDA/EMA-approved drugs developed in Shanghai labs- 3,200 biotech startups (47% growth since 2022)- $9.8 billion